Skip to content

The Effect of Anterior Cervical Fusion Segment Selection on the Surgical Outcome of Hirayama Disease

The Effect of Anterior Cervical Fusion Segment Selection on the Surgical Outcome of Hirayama Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021216
Enrollment
Unknown
Registered
2019-02-01
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirayama Disease

Interventions

C4-6:fusion segment C4-6
C5-7:fusion segment C5-7

Sponsors

Huashan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
14 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. occurrence of the disease before 25 years of age; 2. insidious onset of asymmetrical focal weakness and wasting of the distal upper limbs; 3. insidious onset with slow progression for over 6months; 4. absence of significant sensory complaints and lower limbs symptoms.

Exclusion criteria

Exclusion criteria: 1) Combined with limb fractures, brain trauma, patients with polyneuropathy, plexus disease, focal neuropathy other than radiculopathy, myopathy or central nervous system disease; 2) patients with other surgical contraindications that cannot be treated surgically; 3) responsible segment can be determined by imaging examination.

Design outcomes

Primary

MeasureTime frame
cervical mobility;cervical curvature;

Secondary

MeasureTime frame
F-wave minimum latency;F-wave occurrence rate;F-wave amplitude;F-wave time dispersion;MUNE;DASH score;

Countries

China

Contacts

Public ContactJIANG Jianyuan

12 Middle Wulumuqi Road, Jing'an District, Shanghai, China

jianyuanjiang05@126.com+86 18817362749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026